-
FDA sets May 2027 decision date on AMT-130 gene therapy for HD
4 min read
Latest News
-
New study sheds light on regional degeneration in HD
8 min read
Why do certain brain cells die in HD? New research suggests is may be due to the efficiency of cellular recycling
-
Buzzilia Video: Day 3
19 min read
Video from day 3 of Buzzilia: nightly news, interviews and features from the HD World Congress 2013 in Brazil
-
Buzzilia Video: Day 2
18 min read
Video from day 2 of Buzzilia: nightly news, interviews and features from the HD World Congress 2013 in Brazil
-
What the 'big neurodegeneration breakthrough' means for Huntington's disease
10 min read
Are recent findings in mice injected with 'prions' as important for Huntington's disease as widely reported?
-
The sweet lowdown: Huntington's disease brains use sugar differently
7 min read
New observations suggest that the brains of HD mutation carriers consume energy differently. Do we care? (Yes!)
-
Buzzilia Video: Day 1
16 min read
Buzzilia video: Day 1. Highlights of the 2013 HD World Congress in Brazil: nightly news, interviews and features
-
Video feature: Huntington's disease research… in space!
12 min read
The sky's no longer the limit for HD research: HDBuzz interviews Gwen Owens, who's sending the HD protein into space!
-
'Buzzilia' from the Huntington's Disease World Congress: day 4
7 min read
#Buzzilia, day 4: Jeff and Ed's roundup of happenings from the closing day of the HD World Congress in Rio de Janeiro
-
'Buzzilia' from the Huntington's Disease World Congress: day 3
9 min read
#Buzzilia, day 3: Jeff and Ed's roundup of happenings from the third day of the HD World Congress in Rio de Janeiro
-
'Buzzilia' from the Huntington's Disease World Congress: day 2
12 min read
#Buzzilia, day 2: Jeff and Ed's roundup of happenings from the second day of the HD World Congress in Rio de Janeiro
HDBuzz Trial Tracker
FDA accepts BLA for Priority Review, with a target decision date of 1 May 2027.
Show 8 more Show less
Updates from the ongoing Phase 3 INVEST-HD trial of votoplam
Updates from the Phase 1b/2a REGEN4HD trial of neural stem cell therapy hNSC-01
Updates from the ongoing Phase 2/3 FALCON-HD trial of SKY-0515
